Full Text View
Tabular View
No Study Results Posted
Related Studies
Pentavalent DTaP-Hep B-IPV
This study has been completed.
Study NCT00133445   Information provided by National Institute of Allergy and Infectious Diseases (NIAID)
First Received: August 19, 2005   Last Updated: November 19, 2009   History of Changes
Related Studies can be found by searching for the Conditions, Interventions, and Sponsors found in this study:
Conditions listed in this trial
Diphtheria
Hepatitis B
Pertussis
Tetanus
Poliomyelitis
Additional conditions recognized in this trial
Hepatitis
Whooping Cough
More general conditions related to this trial
Actinomycetales Infections
Bacterial Infections
Bordetella Infections
Central Nervous System Diseases
Central Nervous System Infections
Central Nervous System Viral Diseases
Clostridium Infections
Corynebacterium Infections
Digestive System Diseases
DNA Virus Infections
Enterovirus Infections
Gram-Negative Bacterial Infections
Gram-Positive Bacterial Infections
Hepadnaviridae Infections
Hepatitis, Viral, Human
Infection
Liver Diseases
Motor Neuron Disease
Myelitis
Nervous System Diseases
Neuromuscular Diseases
Picornaviridae Infections
Respiratory Tract Diseases
Respiratory Tract Infections
RNA Virus Infections
Spinal Cord Diseases
Virus Diseases
Interventions listed in this trial
DTaP-Hep B-IPV Vaccine
Monovalent Hep B Vaccine
Placebo
Sponsors listed in this trial
National Institute of Allergy and Infectious Diseases (NIAID)


Contact Help Desk
Lister Hill National Center for Biomedical Communications,  U.S. National Library of Medicine,
U.S. National Institutes of Health,  U.S. Department of Health & Human Services,
USA.gov,  Copyright,  Privacy,  Accessibility,  Freedom of Information Act

U.S. National Institutes of Health U.S. National Library of Medicine U.S. Department of Health & Human Services